Trial Profile
Phase I study of lapatinib in combination with gemcitabine in patients with advanced breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2017
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 06 Nov 2017 New trial record